Table 1.
Demographic and clinical characteristics of the population.
| Variable | Converters (N = 36) | Non-converters (N = 56) | P-value (Mann-Whitney or Fisher test) |
|---|---|---|---|
| Age | 20.0 (2.53) | 21.8 (3.65) | 0.023 |
| Sex ratio (male/female) | 27/9 | 30/26 | 0.049 |
| Tobacco (daily use) | 50% | 35.4% | 0.25 |
| Cannabis (use in the last 30 days) | 37.5% | 20.5% | 0.12 |
| Psychotropic medication at inclusion | 62% | 60% | 1 |
| Follow-up duration in months | 9.8 (5.7) | 13.7 (4.0) | 0.002 |
| BPRS at baseline | 56.03 (13.88) | 54.79 (12.11) | 0.93 |
| BPRS at the end of the follow-up | 52.54 (14.00) | 44.45 (11.36) | 0.016 |
| CGI at baseline | 4.53 (0.84) | 4.59 (0.82) | 0.7 |
| CGI at the end of the follow-up | 4.78 (0.85) | 3.74 (1.20) | <10−3 |
| Quality of RNA measured by RIN | 8.51 (0.45) | 8.38 (0.54) | 0.11 |
BPRS (Brief Psychiatric Rating Scale); CGI (Clinical Global Impressions Scale). P-values <0.05 are in bold. Values represent population mean (and standard deviation).